Controlled Substance Market Size to Hit USD 165.36 Bn By 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Controlled Substance Market

5.1. COVID-19 Landscape: Controlled Substance Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Controlled Substance Market, By Drug

8.1. Controlled Substance Market, by Drug

8.1.1 Opioids

8.1.1.1. Market Revenue and Forecast

8.1.2. Stimulant

8.1.2.1. Market Revenue and Forecast

8.1.3. Depressants

8.1.3.1. Market Revenue and Forecast

8.1.4. Cannabinoids

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Controlled Substance Market, By Application

9.1. Controlled Substance Market, by Application

9.1.1. ADHD

9.1.1.1. Market Revenue and Forecast

9.1.2. Pain Management

9.1.2.1. Market Revenue and Forecast

9.1.3. Depression

9.1.3.1. Market Revenue and Forecast

9.1.4. Sleep Disorder

9.1.4.1. Market Revenue and Forecast

9.1.6. Cough Suppression

9.1.6.1. Market Revenue and Forecast

9.1.7. Anxiety

9.1.7.1. Market Revenue and Forecast

9.1.8. Seizures

9.1.8.1. Market Revenue and Forecast

9.1.9. Others

9.1.9.1. Market Revenue and Forecast

Chapter 10. Global Controlled Substance Market, By Distribution

10.1. Controlled Substance Market, by Distribution

10.1.1. Hospital Pharmacy

10.1.1.1. Market Revenue and Forecast

10.1.2. Retail Pharmacy

10.1.2.1. Market Revenue and Forecast

10.1.3. Online Pharmacy

10.1.3.1. Market Revenue and Forecast

Chapter 11. Global Controlled Substance Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Drug

11.1.2. Market Revenue and Forecast, by Application

11.1.3. Market Revenue and Forecast, by Distribution

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Drug

11.1.4.2. Market Revenue and Forecast, by Application

11.1.4.3. Market Revenue and Forecast, by Distribution

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Drug

11.1.5.2. Market Revenue and Forecast, by Application

11.1.5.3. Market Revenue and Forecast, by Distribution

11.2. Europe

11.2.1. Market Revenue and Forecast, by Drug

11.2.2. Market Revenue and Forecast, by Application

11.2.3. Market Revenue and Forecast, by Distribution

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Drug

11.2.4.2. Market Revenue and Forecast, by Application

11.2.4.3. Market Revenue and Forecast, by Distribution

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Drug

11.2.5.2. Market Revenue and Forecast, by Application

11.2.5.3. Market Revenue and Forecast, by Distribution

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Drug

11.2.6.2. Market Revenue and Forecast, by Application

11.2.6.3. Market Revenue and Forecast, by Distribution

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Drug

11.2.7.2. Market Revenue and Forecast, by Application

11.2.7.3. Market Revenue and Forecast, by Distribution

11.3. APAC

11.3.1. Market Revenue and Forecast, by Drug

11.3.2. Market Revenue and Forecast, by Application

11.3.3. Market Revenue and Forecast, by Distribution

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Drug

11.3.4.2. Market Revenue and Forecast, by Application

11.3.4.3. Market Revenue and Forecast, by Distribution

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Drug

11.3.5.2. Market Revenue and Forecast, by Application

11.3.5.3. Market Revenue and Forecast, by Distribution

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Drug

11.3.6.2. Market Revenue and Forecast, by Application

11.3.6.3. Market Revenue and Forecast, by Distribution

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Drug

11.3.7.2. Market Revenue and Forecast, by Application

11.3.7.3. Market Revenue and Forecast, by Distribution

11.4. MEA

11.4.1. Market Revenue and Forecast, by Drug

11.4.2. Market Revenue and Forecast, by Application

11.4.3. Market Revenue and Forecast, by Distribution

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Drug

11.4.4.2. Market Revenue and Forecast, by Application

11.4.4.3. Market Revenue and Forecast, by Distribution

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Drug

11.4.5.2. Market Revenue and Forecast, by Application

11.4.5.3. Market Revenue and Forecast, by Distribution

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Drug

11.4.6.2. Market Revenue and Forecast, by Application

11.4.6.3. Market Revenue and Forecast, by Distribution

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Drug

11.4.7.2. Market Revenue and Forecast, by Application

11.4.7.3. Market Revenue and Forecast, by Distribution

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Drug

11.5.2. Market Revenue and Forecast, by Application

11.5.3. Market Revenue and Forecast, by Distribution

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Drug

11.5.4.2. Market Revenue and Forecast, by Application

11.5.4.3. Market Revenue and Forecast, by Distribution

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Drug

11.5.5.2. Market Revenue and Forecast, by Application

11.5.5.3. Market Revenue and Forecast, by Distribution

Chapter 12. Company Profiles

12.1. Merck & Co. Inc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Johnson & Johnson

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Orbis Biosciences

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Aradigm Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Corium International

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. G.W. Pharmaceuticals

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Lannett

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global controlled substance market size is accounted at USD 98.70 billion in 2025 and it is expected to reach around USD 165.36 billion by 2035.

The global controlled substance market is poised to grow at a CAGR of 5.30% from 2026 to 2035.

The major players operating in the controlled substance market are Merck & Co. Inc, Johnson & Johnson, Orbis Biosciences, Aradigm Corporation, Corium International, G.W. Pharmaceuticals, Lannett and Others.

The driving factors of the controlled substance market are the increased research & development (R&D) investment to discover controlled drugs and increasing prevalence of chronic diseases.

North America region will lead the global controlled substance market during the forecast period 2026 to 2035.